Panel Discussion: Working Around Clinical Trial Challenges for Retinal Vascular Disease Drug Development
Time: 5:15 pm
day: Day One
Details:
• Discussing challenges of getting the next generation of therapeutics approved for DME and nAMD
• Highlighting the novel end points beyond BCVA to establish meaningful differentiation from VEGF therapy
• Overcoming challenges with regulators and payers to get approval and funding for therapies
